ÂÜÀòÂÒÂ×

Yanping Qi currently serves as Director of Research IT at Regeneron Pharmaceuticals, Inc., focusing on supporting PreClinical Development and Drug Safety Pharmacometrics. Responsibilities include collaboration with business stakeholders to develop scientific informatics strategies, managing project portfolios, and delivering high-power computing solutions to enhance modeling and simulation processes. Previously, Yanping Qi worked at AstraZeneca as Associate Director, where leadership in scientific IS supported timely decision-making for Translational Scientists. Earlier experience includes roles at Amgen, managing IT service processes, developing digital strategies for Safety Surveillance, and leading significant application implementations. Yanping Qi holds a Ph.D. in Neuroscience from Tufts University, a certificate in Computer Science from North Carolina State University, and a Bachelor's Degree in Animal Sciences from China Agricultural University.